Award recordCONTRACT

NUCLEAR DIAGNOSTIC PRODUCTS, INC

PIID VA24414C0009· VHA· 642-PHILADELPHIA· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2014· $362,597 net obligations· UEI RQAKL78AXMT5· NJ

Description

IGF::OT::IGF RADIOPHARMACEUTICAL SUPPLIES

First action · last action
2013-10-01 · 2015-03-03
Transactions
3
First transaction's obligation
$222,953
Base + all options value (sum of deltas)
$362,597
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
446110 · PHARMACIES AND DRUG STORES

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$372,953$0Base award · 2013-10-01 · this action $222,953 · running total $222,953Modification P00001 · 2014-04-01 · this action $150,000 · running total $372,953Modification P00002 · 2015-03-03 · this action -$10,356 · running total $362,597
  • Base2013-10-01+$222,953= $222,953
  • Mod P000012014-04-01+$150,000= $372,953
  • Mod P000022015-03-03-$10,356= $362,597
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-10-01+$222,953$222,953IGF::OT::IGF RADIOPHARMACEUTICAL SUPPLIES
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2014-04-01+$150,000$372,953IGF::OT::IGF RADIOPHARMACEUTICAL SUPPLIES
Mod P00002· CLOSE OUT2015-03-03−$10,356$362,597IGF::OT::IGF RADIOPHARMACEUTICAL SUPPLIES

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI RQAKL78AXMT5)

AwardOffice · PSC / listingNet obligationsFY
36C24226P0481242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$3,356,110FY2026
36C24426P0225244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$148,383FY2026
36C24226D0037242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24226N0381242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$959,170FY2026
36C24425N0451244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$180,327FY2025
36C24225N0376242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$51,681FY2025

Other recipients under 6550 from 642-PHILADELPHIA (most recent first)

AwardRecipientOfficeNet obligationsFY
VA24415D0001NUCLEAR DIAGNOSTIC PRODUCTS OF PHILADELPHIA, INC642-PHILADELPHIA$0FY2014
VA24414P2552RESEARCH AND DIAGNOSTIC SYSTEMS, INC642-PHILADELPHIA$4,985FY2014
VA24414P2554TRIPATH IMAGING, INC.642-PHILADELPHIA$4,430FY2014
VA24414F2395ROCHE DIAGNOSTICS CORPORATION642-PHILADELPHIA$11,189FY2014
VA24414P1667LIFE TECHNOLOGIES CORPORATION642-PHILADELPHIA$14,900FY2014

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24414C0009_3600_-NONE-_-NONE- · retrieved 2026-09-26.